Development and validation of serological dynamic risk score to predict outcome in gastric cancer with adjuvant chemotherapy: a multicentre, longitudinal, cohort study

Development and validation of serological dynamic risk score to predict outcome in gastric cancer with adjuvant chemotherapy: a multicentre, longitudinal, cohort study

BackgroundBaseline serological biomarkers have the potential to predict the benefits of adjuvant chemotherapy in patients with gastric cancer. However, the fluctuating nature of postoperative recurrence risk makes precise treatment challenging. We aimed to develop a risk score in real-time predictin...

Full description

Bibliographic Details
Main Authors:	Linbin Lu, Wenzheng Fang, Jun Yu, Xianchun Gao, Xinlin Wang, Yan Pan, Weili Han, Junya Yan, Huahong Xie, Liping Yao, Jianjun Yang, Jianyong Zheng, Liu Hong, Jipeng Li, Mengbin Li, Lei Shang, Kaichun Wu, Gang Ji, Yongzhan Nie
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Oncology
Subjects:	gastric cancer gastrectomy adjuvant chemotherapy predictive model risk score risk state chains
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1327691/full

Similar Items

ADJUVANT CHEMORADIOTHERAPY AFTER SUBTOTAL OR TOTAL GASTRECTOMY AND D2 LIMPHADENECTOMY INCREASES SURVIVAL IN ADVANCED GASTRIC CANCER?
by: Nelson Adami ANDREOLLO, et al.
Published: (2019-12-01)

Adjuvant Chemoradiotherapy for Gastric Cancer: Efficacy and Cost-Effectiveness Analysis
by: Mengxi Zhang, et al.
Published: (2019-12-01)

Association of survival with adjuvant chemotherapy in patients with stage IB gastric cancer: a multicentre, observational, cohort studyResearch in context
by: Xianchun Gao, et al.
Published: (2024-04-01)

Where do we stand on adjuvant melanoma therapy?
by: Ana L. Matos, et al.
Published: (2022-10-01)

Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S‐1 chemotherapy after gastrectomy: A multicenter, open‐label, single‐arm, prospective phase II study (OGSG1108)
by: Hiroshi Imamura, et al.
Published: (2021-11-01)

Adjuvant Chemotherapy Might Be Recommended to Patients With Positive Margin After Gastrectomy: A 20-Year Retrospective Analysis in a Single Center
by: Xiaojie Zhang, et al.
Published: (2022-02-01)

Perspectives in adjuvant gastric cancer therapy
by: Wils Jacques
Published: (2003-01-01)

Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients
by: Yu S, et al.
Published: (2020-10-01)

Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol
by: Tsutomu Namikawa, et al.
Published: (2018-02-01)

Elevated postoperative carcinoembryonic antigen guides adjuvant chemotherapy for stage II colon cancer: a multicentre cohort retrospective study
by: Hongjiang Pu, et al.
Published: (2024-03-01)

Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma
by: Yan Zheng, et al.
Published: (2021-09-01)

Role of Adjuvant Radiotherapy in Patients with Cervical Cancer Undergoing Radical Hysterectomy
by: María Alonso-Espías, et al.
Published: (2023-10-01)

Association of CDX2 and mucin expression with chemotherapeutic benefits in patients with stage II/III gastric cancer
by: Xianchun Gao, et al.
Published: (2023-09-01)

Factores de riesgo asociados con morbilidad y mortalidad postoperatoria en gastrectomía radical D2 por cáncer gástrico
by: O.R. Paredes-Torres, et al.
Published: (2022-04-01)

Is Adjuvant Radiotherapy Effective in Intermediate-risk Surgical Stage I Endometrial Cancer?
by: Hung-Chuan Yu, et al.
Published: (2004-06-01)

Risk factors for hypokalemia and its association with postoperative recovery in patients scheduled for radical gastrectomy: a retrospective study
by: Min Yang, et al.
Published: (2023-08-01)

Ignoring Adjuvant Toxicity Falsifies the Safety Profile of Commercial Pesticides
by: Robin Mesnage, et al.
Published: (2018-01-01)

Adjuvant Ipilimumab in High-Risk Uveal Melanoma
by: Eric Fountain, et al.
Published: (2019-01-01)

Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
by: Shaheer Khan, et al.
Published: (2022-08-01)

Adjuvant Effects on Pyraclostrobin and Boscalid Residues, Systemic Movement, and Dietary Risk in Garlic under Field Conditions
by: Paraskevas Parlakidis, et al.
Published: (2023-08-01)

Open Surgery including Lymphadenectomy without Adjuvant Therapy for Uterine-Confined Intermediate- and High-Risk Endometrioid Endometrial Carcinoma
by: Isao Otsuka, et al.
Published: (2022-05-01)

Potentials of saponins-based adjuvants for nasal vaccines
by: Kai Chen, et al.
Published: (2023-03-01)

Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
by: Zi-Qing Shen, et al.
Published: (2024-01-01)

Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients
by: Yujin Lee, et al.
Published: (2021-10-01)

Adjuvant Chemotherapy for Stage II Colon Cancer
by: Sara Elena Rebuzzi, et al.
Published: (2020-09-01)

Adjuvant chemoradiotherapy in resected gallbladder cancer: A SEER-based study
by: Yong Jiang, et al.
Published: (2023-03-01)

Risk factors for death from other diseases after curative gastrectomy and lymph node dissection for gastric cancer
by: Takaaki Hanyu, et al.
Published: (2024-01-01)

Immunogenicity of Different Types of Adjuvants and Nano-Adjuvants in Veterinary Vaccines: A Comprehensive Review
by: Soren Nooraei, et al.
Published: (2023-02-01)

Carcinoma Stomach: Unwanted Chemotherapeutic Success: A Case Vignette
by: Sapam Opendro Singh, et al.
Published: (2013-12-01)

Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study
by: Kexuan Li, et al.
Published: (2023-09-01)

Current Situation of Postoperative Adjuvant Chemoradiotherapy for Extrahepatic Cholangiocarcinoma
by: YANG Xiao, et al.
Published: (2023-01-01)

SEROLOGICAL RESPONSE OF BUFFALOES AND CALVES VACCINATED WITH OIL ADJUV ANT HAEMORRHAGIC SEPTICAEMIA VACCINE
by: Rashid Ahmad,
Published: (2003-04-01)

Analysis of postoperative pulmonary complications after gastrectomy for gastric cancer: development and validation of a nomogram
by: Ling Zhou, et al.
Published: (2023-12-01)

Risk Factors for Early and Late Complications after Laparoscopic Sleeve Gastrectomy in One-Year Observation
by: Paulina Głuszyńska, et al.
Published: (2022-01-01)

Risk factors for non‐gastric‐cancer‐related death after gastrectomy in elderly patients
by: Michihisa Iida, et al.
Published: (2022-11-01)

A New Nomogram Based on Early Postoperative NLR for Predicting Infectious Complications After Gastrectomy
by: Wang C, et al.
Published: (2020-02-01)

Patient-reported gastrointestinal symptoms following surgery for gastric cancer and the relative risk factors
by: Rui Xu, et al.
Published: (2022-09-01)

Eating to live or living to eat: The meaning of hunger following gastric surgery
by: Nina Hallowell, et al.
Published: (2021-12-01)

Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment
by: Camilla Nero, et al.
Published: (2021-09-01)

An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-04-01)